Retraction: Tumor Microenvironment in Oral Cancer Following Neoadjuvant Pembrolizumab: Preliminary Analysis of the Histopathologic Findings

Retraction: Tumor Microenvironment in Oral Cancer Following Neoadjuvant Pembrolizumab: Preliminary Analysis of the Histopathologic Findings

Bibliographic Details
Main Author:	Frontiers Editorial Office
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2022-03-01
Series:	Frontiers in Oral Health
Online Access:	https://www.frontiersin.org/articles/10.3389/froh.2022.893486/full

Similar Items

RETRACTED: Tumor Microenvironment in Oral Cancer Following Neoadjuvant Pembrolizumab: Preliminary Analysis of the Histopathologic Findings
by: Alex Dobriyan, et al.
Published: (2021-04-01)

Retraction: Neoadjuvant Therapy for Esophageal Adenocarcinoma in the Community Setting—Practice and Outcomes
by: Frontiers Editorial Office
Published: (2019-04-01)

Retraction: The value, diagnostic efficacy and clinical significance of functional magnetic resonance imaging in evaluating the efficacy of neoadjuvant chemotherapy in patients with triple negative breast cancer
by: Frontiers Editorial Office
Published: (2024-02-01)

Retraction: The Collective Effect of MIP-3α and FL Promotes Dendritic Cell Function Within the Immune Microenvironment of Murine Liver Cancer
by: Frontiers Editorial Office
Published: (2021-08-01)

Retraction: A deep learning model for three-dimensional nystagmus detection and its preliminary application
by: Frontiers Editorial Office
Published: (2023-12-01)

Retraction: Elevated Expression Levels of PC3-Secreted Microprotein (PSMP) in Prostate Cancer Associated With Increased Xenograft Growth and Modification of Immune-Related Microenvironment
by: Frontiers Editorial Office
Published: (2020-12-01)

Neoadjuvant pembrolizumab in advanced melanoma
by: Praful Pandey, et al.
Published: (2023-01-01)

Retraction: CAR-NK Cell: a new paradigm in tumor immunotherapy
by: Frontiers Editorial Office
Published: (2023-09-01)

Retraction: Longitude variation of the microRNA-497/FGF-23 axis during treatment and its linkage with neoadjuvant/adjuvant trastuzumab-induced cardiotoxicity in HER2-positive breast cancer patients
by: Frontiers Editorial Office
Published: (2023-10-01)

Retraction: The turnaway study: A case of self-correction in science upended by political motivation and unvetted findings
by: Frontiers Editorial Office
Published: (2022-12-01)

Retraction: Identification of hub genes and construction of prognostic nomogram for patients with Wilms tumors
by: Frontiers Editorial Office
Published: (2023-10-01)

Retraction: CRISPR/Cas9-Mediated OC-2 Editing Inhibits the Tumor Growth and Angiogenesis of Ovarian Cancer
by: Frontiers Editorial Office
Published: (2021-05-01)

Retraction: Oroxylin a Inhibits the Protection of Bone Marrow Microenvironment on CML Cells Through CXCL12/CXCR4/P-gp Signaling Pathway
by: Frontiers Editorial Office
Published: (2020-04-01)

Retraction: Oral administration of brain protein combined with probiotics induces immune tolerance through the tryptophan pathway
by: Frontiers Editorial Office
Published: (2023-08-01)

Retraction: Application of biosensors in cancers, an overview
by: Frontiers Editorial Office
Published: (2023-12-01)

Retraction: PBTNet: a new computer-aided diagnosis system for detecting primary brain tumors
by: Frontiers Editorial Office
Published: (2024-01-01)

Retraction: The oncolytic virus in cancer diagnosis and treatment
by: Frontiers Editorial Office
Published: (2023-11-01)

Retraction: Mesenchymal stem/stromal cells as a vehicle for cytokine delivery: an emerging approach for tumor immunotherapy
by: Frontiers Editorial Office
Published: (2023-09-01)

Retraction: The Design, Characterizations, and Tumor Angiogenesis Inhibition of a Multi-Epitope Peptibody With bFGF/VEGFA
by: Frontiers Editorial Office
Published: (2021-01-01)

Retraction: Chitosan-Coated Titanium Dioxide-Embedded Paclitaxel Nanoparticles Enhance Anti-Tumor Efficacy Against Osteosarcoma
by: Frontiers Editorial Office
Published: (2021-06-01)

Retraction: The role of microRNAs in the tumorigenesis of ovarian cancer
by: Frontiers Editorial Office
Published: (2020-04-01)

Retraction: MicroRNA-326 functions as a tumor suppressor in breast cancer by targeting ErbB/PI3K signaling pathway
by: Frontiers Editorial Office
Published: (2023-10-01)

Retraction: Adverse Pregnancy Outcomes Following Exposure to Biologics in Women With Crohn's Disease: A Systematic Review and Meta-Analysis
by: Frontiers Editorial Office
Published: (2022-04-01)

Retraction: STAT3 Promotes Invasion and Aerobic Glycolysis of Human Oral Squamous Cell Carcinoma via Inhibiting FoxO1
by: Frontiers Editorial Office
Published: (2021-09-01)

Retraction: Frequencies of Porphyromonas gingivalis detection in oral-digestive tract tumors
by: Pathology and Oncology Research Editorial Office
Published: (2023-12-01)

Retraction: Green Synthesis of Metallic Nanoparticles and Their Potential Applications to Treat Cancer
by: Frontiers Editorial Office
Published: (2023-01-01)

A Phase 1 Study of Concurrent Neoadjuvant Pembrolizumab Plus Chemoradiation Followed by Consolidation Pembrolizumab in Patients With Resectable Stage IIIA NSCLC
by: Christopher A. Lemmon, MD, et al.
Published: (2022-07-01)

Retraction: Curcumin-Free Turmeric Exhibits Activity against Human HCT-116 Colon Tumor Xenograft: Comparison with Curcumin and Whole Turmeric
by: Frontiers Editorial Office
Published: (2018-04-01)

Erratum: Immune Tumor Microenvironment in Breast Cancer and the Participation of Estrogen and Its Receptors in Cancer Physiopathology
by: Frontiers Production Office
Published: (2019-08-01)

Retraction: GMO debate: inconclusive
by: Frontiers in Genetics Editorial Office
Published: (2013-08-01)

Retraction: Harnessing TRAIL-induced apoptosis pathway for cancer immunotherapy and associated challenges
by: Frontiers Editorial Office
Published: (2023-09-01)

Retraction: A novel tumor suppressor gene, ZFN24, inhibits the development of NSCLC by inhibiting the Wnt signaling pathway to induce cell senescence
by: Frontiers Editorial Office
Published: (2022-09-01)

Retraction: Mechanisms Contributing to the Generation of Mayer Waves
by: Frontiers Editorial Office
Published: (2021-11-01)

Retraction: Magnetic resonance imaging and 18F-fludeoxyglucose positron emission tomography/computed tomography findings of retroperitoneal clear cell carcinoma with an unknown primary site: a case report
by: Frontiers Editorial Office
Published: (2023-09-01)

Retraction: Quercetin inhibits tumorigenesis of colorectal cancer through downregulation of hsa_circ_0006990
by: Frontiers Editorial Office
Published: (2023-07-01)

Retraction: RBFOX3 Promotes Gastric Cancer Growth and Progression by Activating HTERT Signaling
by: Frontiers Editorial Office
Published: (2021-08-01)

Erratum: Development of immunotherapy strategies targeting tumor microenvironment is fiercely ongoing
by: Frontiers Production Office
Published: (2022-08-01)

Retraction: Overexpressed tumor suppressor exosomal miR-15a-5p in cancer cells inhibits PD1 expression in CD8+T cells and suppresses the hepatocellular carcinoma progression
by: Frontiers Editorial Office
Published: (2024-03-01)

Retraction: Kinesin family member 2A serves as a potential biomarker reflecting more frequent lymph node metastasis and tumor recurrence risk in basal-like breast cancer patients
by: Frontiers Editorial Office
Published: (2023-10-01)

Retraction: Benchmarking neuromorphic systems with Nengo
by: Frontiers in Neuroscience Editorial Office
Published: (2015-11-01)